X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14) 14
immunotherapy (12) 12
index medicus (12) 12
oncology (8) 8
brain neoplasms - pathology (6) 6
glioblastoma (6) 6
glioma (6) 6
adult (5) 5
female (5) 5
lymphocytes (5) 5
brain neoplasms - therapy (4) 4
glioma - therapy (4) 4
immunology (4) 4
magnetic resonance imaging (4) 4
middle aged (4) 4
animals (3) 3
brain neoplasms - drug therapy (3) 3
cancer (3) 3
cancer vaccines - therapeutic use (3) 3
case report (3) 3
clinical neurology (3) 3
clinical trials (3) 3
ima950 (3) 3
lymphocytes t (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
peptide vaccine (3) 3
survival (3) 3
temozolomide (3) 3
tumors (3) 3
vaccination (3) 3
adjuvants (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antigen (2) 2
antigens (2) 2
brain (2) 2
brain cancer (2) 2
brain neoplasms - immunology (2) 2
cancer therapies (2) 2
cancer vaccines (2) 2
cancer-immunotherapy (2) 2
central-nervous-system (2) 2
combination (2) 2
glioma - immunology (2) 2
glioma - pathology (2) 2
history (2) 2
identification (2) 2
immune checkpoint (2) 2
immune-responses (2) 2
immunotherapy - methods (2) 2
male (2) 2
melanoma (2) 2
mutation (2) 2
patients (2) 2
peptides (2) 2
poly-iclc (2) 2
prognosis (2) 2
strategies (2) 2
studies (2) 2
t-cells (2) 2
tumor (2) 2
tumor microenvironment (2) 2
tumor-infiltrating lymphocytes (2) 2
usage (2) 2
vaccines (2) 2
170 ethics (1) 1
1st-episode psychosis (1) 1
20th century (1) 1
214 (1) 1
570 life sciences; biology (1) 1
610 medicine & health (1) 1
abridged index medicus (1) 1
action potentials - physiology (1) 1
adaptive immunity (1) 1
adjuvant temozolomide (1) 1
adolescent (1) 1
affect - physiology (1) 1
amino acids (1) 1
anaplastic meningioma (1) 1
anergy (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anti-muc1 monoclonal-antibody (1) 1
anti-pd-1 antibody (1) 1
antigen peptides (1) 1
antigen receptors (1) 1
antigens, neoplasm - immunology (1) 1
antineoplastic agents - therapeutic use (1) 1
antitumor immunity (1) 1
antitumor-activity (1) 1
arachidonic acid - blood (1) 1
arachidonic-acid (1) 1
architecture (1) 1
architecture, modern (1) 1
article (1) 1
astrocytoma (1) 1
astrocytoma - diagnosis (1) 1
astrocytoma - metabolism (1) 1
astrocytoma - surgery (1) 1
attentional tests (1) 1
bace2 (1) 1
beta cells (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuro-Oncology, ISSN 1522-8517, 11/2016, Volume 18, Issue suppl_6, pp. vi22 - vi22
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2018, Volume 24, Issue 3, pp. 535 - 540
Glioblastoma is an aggressive malignancy with a poor prognosis. The current standard of care for newly diagnosed glioblastoma patients includes surgery to the... 
Brain | Trafficking | Glioblastoma | Central nervous system | Clinical trials | Lymphocytes T | Malignancy | Radiation therapy | ErbB-2 protein | Immunosuppression | Glioma | Lymphocytes | Medical prognosis | Surgery | Interleukin 1 | Temozolomide | Cancer
Journal Article
Current Opinion in Oncology, ISSN 1040-8746, 11/2019, Volume 31, Issue 6, pp. 514 - 521
PURPOSE OF REVIEWImmunotherapy is viewed as a promising approach for glioblastoma and, in particular, therapeutic vaccines are being intensively studied. Here,... 
Cancer vaccines | Usage | Drug therapy | Glioblastoma multiforme | Immunotherapy | Testing
Journal Article
Nature, ISSN 0028-0836, 01/2019, Volume 565, Issue 7738, pp. 240 - 245
Journal Article
ILAR Journal, ISSN 1084-2020, 12/2018, Volume 59, Issue 3, pp. 276 - 285
Abstract The cellular immunotherapy field has achieved important milestones in the last 30 years towards the treatment of a variety of cancers due to... 
Journal Article
Revue medicale suisse, ISSN 1660-9379, 04/2016, Volume 12, Issue 516, p. 828
Glioblastomas are highly aggressive tumors. Their prognosis remain poor despite standard therapies combining surgery, radiation and temozolomide based... 
Glioblastoma - therapy | Immunotherapy - methods | Prognosis | Glioblastoma - pathology | Humans | Brain Neoplasms - pathology | Brain Neoplasms - therapy
Journal Article
Revue Medicale Suisse, ISSN 1660-9379, 04/2016, Volume 12, Issue 516, pp. 828 - 831
Journal Article
CANCERS, ISSN 2072-6694, 04/2019, Volume 11, Issue 4, p. 464
Immunotherapy, including therapeutic vaccines, is increasingly being developed for patients with high-grade glioma, and combinations of immunotherapies and... 
SURVIVAL | LOMUSTINE | COMBINATION | ADJUVANT TEMOZOLOMIDE | GLIOBLASTOMA | ONCOLOGY | immunotherapy | SINGLE-AGENT BEVACIZUMAB | bevacizumab | glioma | IMA950 | NORMALIZATION | RADIOTHERAPY | peptide vaccine | CHECKPOINTS | ENDOTHELIAL GROWTH-FACTOR
Journal Article
Glycobiology, ISSN 0959-6658, 2018, Volume 28, Issue 9, pp. 656 - 669
Journal Article
Bulletin du Cancer, ISSN 0007-4551, 05/2017, Volume 104, Issue 5, pp. 476 - 484
Immunotherapy has proven efficient for many tumors and is now part of standard of care in many indications. What is the picture for brain tumors? The recent... 
Glioma | Immunotherapy | Microenvironment
Journal Article
ILAR journal, 05/2019
The cellular immunotherapy field has achieved important milestones in the last 30 years towards the treatment of a variety of cancers due to improvements in... 
Journal Article
Journal of Neurological Surgery Reports, ISSN 2193-6358, 10/2017, Volume 78, Issue 4, pp. e129 - e134
Abstract Anaplastic meningioma is seldom encountered. Moreover, distant metastasis is extremely rare, with only a handful cases reported. Here, we report the... 
Case Report | endoscopic surgery | skull base surgery | Original | oncology | anaplastic meningioma | metastatic meningioma
Journal Article